MedPath

GLAXOSMITHKLINE TRADING SERVICES LIMITED

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

28

CIMA_AEMPS:14
EMA:11
NMPA:3

Drug Approvals

Mepolizumab Injection

Product Name
新可来
Approval Number
国药准字SJ20210029
Approval Date
Nov 17, 2021
NMPA

Mepolizumab Injection

Product Name
新可来
Approval Number
国药准字SJ20210030
Approval Date
Nov 17, 2021
NMPA

Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation

Product Name
氟替美维吸入粉雾剂
Approval Number
H20190055
Approval Date
Apr 7, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.